- Home
- Products
- Resources
- Our Technology
- Support
- About NuGen
- Company
- Leadership
- Press
- NuGEN enters the Next Generation Sequencing arena with the Ovation® RNA-Seq System
- NuGEN Announces the Newest Member of its Applause Product Family
- NuGEN invests in larger state of the art facility while recruiting new research team to prepare for entry into NGS market
- NuGEN enters the Whole Genome Amplification arena with the new Ovation® WGA System
- NuGEN Expands Product Portfolio with New Applause™ Brand RNA Amplification Products
- NuGEN Names Dr. Lutz Kirchrath Managing Director
- NuGEN Introduces WT-Ovation™ One-Direct RNA Amplification System
- NuGEN Taps Erwin Estigarribia to Lead Manufacturing and Quality Operations
- NuGEN Announces Target Preparation Solution For Use with Agilent Dual-Mode Gene Expression Microarrays
- Almac Selects NuGEN Ovation® Systems to Broaden Gene Expression Services and to Use for Diagnostic Test Development
- Ocimum Biosolutions Becomes an Authorized Service Provider for NuGEN Ovation® Systems in India
- NuGEN Expands Executive Team with Finance and Marketing Pros
- Roche Applied Science Pens Co-Research Agreement with NuGEN Technologies for Developing a NimbleGen Array Application
- Asuragen Adds NuGEN Ovation® Systems to Gene Expression Profiling Menu
- NuGEN and Hamilton Create Automated, Total Target Preparation Solution
- NuGEN Receives Patent for Global Nucleic Acid Amplification
- NuGEN Awarded ISO 13485:2003 Medical Devices Certification
- Dr. Douglas Amorese Joins NuGEN as VP, Research and Development
- Roche Selects NuGEN WT-Ovation™ Technology As RNA Amplification Product for LightCycler® System
- NuGEN Launches WT-Ovation™ Exon Module
- Events
- Careers
